Cargando…

Current and Emerging Approaches for Hepatic Fibrosis Treatment

Liver fibrosis resulting from chronic liver injury is a key factor to develop liver cirrhosis and risk of hepatocellular carcinoma (HCC) which are major health burden worldwide. Therefore, it is necessary for antifibrotic therapies to prevent chronic liver disease progression and HCC development. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jingguo, Tuo, Biguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310447/ https://www.ncbi.nlm.nih.gov/pubmed/34326871 http://dx.doi.org/10.1155/2021/6612892

Ejemplares similares

Role of OCT1 in hepatocellular carcinoma
por: Li, Jingguo, et al.
Publicado: (2019)

Regulation of Intestinal Glucose Absorption by Ion Channels and Transporters
por: Chen, Lihong, et al.
Publicado: (2016)

Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms
por: Murphy, Mark P., et al.
Publicado: (2016)

Current and Emerging Approaches for Spine Tumor Treatment
por: Costăchescu, Bogdan, et al.
Publicado: (2022)

Managing pediatric hepatitis C: current and emerging treatment options
por: Karnsakul, Wikrom, et al.
Publicado: (2009)

RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
por: Cheng, Chenglong, et al.
Publicado: (2023)

Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma
por: Swan, Dawn, et al.
Publicado: (2019)

Physiological and pathophysiological role of ion channels and transporters in the colorectum and colorectal cancer
por: Zhang, Minglin, et al.
Publicado: (2020)

Potassium channels as novel molecular targets in hepatocellular carcinoma (Review)
por: Chen, Xingyue, et al.
Publicado: (2023)

Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey
por: Cottin, Vincent
Publicado: (2014)

Function and Expression of Cystic Fibrosis Transmembrane Conductance Regulator after Small Intestinal Transplantation in Mice
por: Song, Penghong, et al.
Publicado: (2013)

Physiological Significance of Ion Transporters and Channels in the Stomach and Pathophysiological Relevance in Gastric Cancer
por: Yuan, Dumin, et al.
Publicado: (2020)

Current and Emerging Therapies to Combat Cystic Fibrosis Lung Infections
por: Manos, Jim
Publicado: (2021)

Cystic fibrosis: current therapeutic targets and future approaches
por: Rafeeq, Misbahuddin M., et al.
Publicado: (2017)

Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer
por: Wang, Hu, et al.
Publicado: (2020)

Understanding the Mechanism of Hepatic Fibrosis and Potential Therapeutic Approaches
por: Ahmad, Areeba, et al.
Publicado: (2012)

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
por: Kreuter, Michael, et al.
Publicado: (2015)

Physiological and Pathophysiological Relevance of the Anion Transporter Slc26a9 in Multiple Organs
por: Liu, Xuemei, et al.
Publicado: (2018)

Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
por: Mohammed, Omima S., et al.
Publicado: (2023)

Treatment of liver fibrosis: Past, current, and future
por: Zhang, Chun-Ye, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis: Current and future treatment
por: Glass, Daniel S., et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
por: Amaral, Alexandre Franco, et al.
Publicado: (2023)

Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis
por: Zehra, Mishghan, et al.
Publicado: (2020)

Role of Ca(2+) channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review)
por: Chen, Xingyue, et al.
Publicado: (2022)

Pathological role of ion channels and transporters in the development and progression of triple-negative breast cancer
por: Lu, Chengli, et al.
Publicado: (2020)

Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus
por: Athanassiou, Panagiotis, et al.
Publicado: (2023)

Endoscopic and pathohistologic features of early gastric signet ring cell carcinoma presented as elevated type: A case report
por: Di, Lianjun, et al.
Publicado: (2022)

Trigeminal Neuralgia: Current Approaches and Emerging Interventions
por: Xu, Risheng, et al.
Publicado: (2021)

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
por: Fajac, Isabelle, et al.
Publicado: (2021)

The mechanisms of gastric mucosal injury: focus on initial chief cell loss as a key target
por: Deng, Zilin, et al.
Publicado: (2023)

Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring
por: El Ayadi, Amina, et al.
Publicado: (2020)

Current trends in the treatment of hepatic encephalopathy
por: Al Sibae, Mohamad Rasm, et al.
Publicado: (2009)

Autoimmune Hepatitis and Fibrosis
por: Pellicano, Rinaldo, et al.
Publicado: (2023)

A Review of Current and Emerging Approaches to Pain Management in the Emergency Department
por: Todd, Knox H.
Publicado: (2017)

Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies
por: Holdhoff, Matthias, et al.
Publicado: (2020)

Autophagy in Hepatic Fibrosis
por: Song, Yang, et al.
Publicado: (2014)

Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
por: Mendes, Leandro César, et al.
Publicado: (2018)

Nanotechnology approaches for inhalation treatment of fibrosis
por: Savla, Ronak, et al.
Publicado: (2013)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
por: Li, Danni, et al.
Publicado: (2023)

Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer
por: Chen, Junling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_76jt1q7ikrh806bukef7q1n5rv